- Senior Managing Director
- Forensic & Litigation Consulting
- T: +1 202 312 9216
- F: +1 202 312 9101
- 555 12th Street, NW
- Suite 700
- Washington, DC, 20004
- United States
- T: +1 202 312 9100
- F: +1 202 312 9101
- B.S., General Studies, Springfield College
- J.D., The Catholic University of America
- Licensed Attorney, Florida (non-active)
- American Bar Association (ABA)
- Florida Bar Association
- Washington Lawyers’ Committee for Civil Rights and Urban Affairs
- Corporate Fraud & Investigations
- Corporate Governance
- Forensic Accounting & Investigations
- Listing Advisory Services
- Regulatory Investigations
- Aerospace & Defense
- Energy, Power & Products
- Financial Institutions
- Public Sector & Government Contracts
- Healthcare & Life Sciences
- Hospitality, Gaming & Leisure
- Retail & Consumer Products
- Telecom, Media & Technology (TMT)
Jason Frankl is a Senior Managing Director at FTI Consulting and is based in Washington. He leads FTI Consulting’s Activism and M&A Solutions practice in which he works with companies that are the subject of shareholder activism and/or M&A activity in the development and implementation of strategies designed to maximize shareholder value. He also advises management teams and boards of directors on how to proactively develop and implement defense strategies. Most recently, Mr. Frankl led a large team of FTI Consulting professionals supporting Allergan in its successful activism/M&A defense involving Pershing Square and Valeant Pharmaceuticals resulting in a white knight bid of $66 billion by Actavis plc. Mr. Frankl also had a leadership role in supporting Perrigo in its successful defense against a hostile takeover bid by Mylan N.V.
Mr. Frankl is also a nationally recognized expert in the areas of NASDAQ and NYSE compliance matters, corporate governance and securities trading. He has counseled hundreds of NASDAQ and NYSE listed companies with an aggregate market capitalization of more than $200 billion on the application and strategies to achieve and regain compliance with U.S. exchange listing requirements.
Mr. Frankl has led dozens of investigations and regulatory inquiries and has provided litigation support on behalf of publicly traded companies, boards of directors, board committees, banks and broker dealers involving NASDAQ, the NYSE, the Financial Industry Regulatory Authority, the Chicago Board Options Exchange, the Securities and Exchange Commission, the Commodity Futures Trading Commission and the U.S. Department of Justice in connection with securities trading matters (equities, options and physicals), activism and M&A defense, regulatory and disclosure requirements, fraud allegations, improper application of generally accepted accounting principles and corporate governance matters.
Prior to joining FTI Consulting, Mr. Frankl served as Counsel with the NASDAQ Stock Market where he conducted and/or was involved in more than 1,000 hearings for issuers faced with the threat of delisting or denial of initial listing for failure to satisfy NASDAQ listing requirements. Mr. Frankl also participated in the development and implementation of NASDAQ’s corporate governance rules and policies formulated in response to the Sarbanes-Oxley Act of 2002, including rules and policies pertaining to shareholder approval, voting rights and board independence.
Mr. Frankl holds a law degree from the Columbus School of Law at Catholic University in Washington and B.S. degree from Springfield College in Springfield, MA. He is actively involved with the Washington Lawyers’ Committee for Civil Rights and Urban Affairs (”WLC”) and serves as the Chairman of the WLC’s Corporate Advisory Board. He is also a member of the Board of Trustees of the Radcliffe Creek School in Chestertown, MD. Mr. Frankl is a supporter of the St. Jude Children’s Research Hospital in Memphis, TN, the National Children’s Hospital in Washington and the Kennedy Krieger Institute in Baltimore.